Search Results

Enrollment complete    Who can join   

A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)

Keywords: Oncology (Adult);Allergy and Immunology;Hematology;
Study Type: Clinical Trial   |  Region: Colorado

---

Enrollment complete    Who can join   

Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma

Keywords: Oncology (Adult);Allergy and Immunology;Hematology;
Study Type: Clinical Trial   |  Region: Colorado

---

Active, currently enrolling    Who can join   

A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age

Keywords: Meningitis; Invasive meningococcal disease; Bexsero; Menveo; Allergy and…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)

Keywords: Oncology (Adult);Allergy and Immunology;Dermatology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

(E5103) A DOUBLE-BLIND PHASE III TRIAL OF DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY PACLITAXEL WITH BEVACIZUMAB OR PLACEBO IN PATIENTS WITH LYMPH NODE POSITIVE AND HIGH RISK LYMPH NODE NEGATIVE BREAST CANCER

Keywords: Oncology (Adult);Allergy and Immunology;Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFR (MATCH Substudy)

Keywords: Oncology (Adult);Allergy and Immunology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

Phase II Study of Sunitinib in Patients with Tumors with cKIT Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuorendocrine Tumor) (MATCH Substudy)

Keywords: Oncology (Adult);Allergy and Immunology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

Intergroup Randomized Phase II Four Arm Study in Patients With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab + Bendamustine Followed By Rituximab Consolidation (RB ? R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV ? R), Arm C ...

Keywords: Oncology (Adult);Allergy and Immunology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

Molecular Analysis for Therapy Choice (MATCH)

Keywords: Oncology (Adult);Allergy and Immunology;Genetics;
Study Type: INTERVENTIONAL   |  Region: Colorado

---

Enrollment complete    Who can join   

(E1697) PHASE III RANDOMIZED STUDY OF FOUR WEEKS HIGH DOSE IFN-2b in Stage T2b No, T3a-b No, T4a-b No, and T1-4, N1a, 2a, 3 (microscopic) MELANOMA

Keywords: Oncology (Adult);Allergy and Immunology;Dermatology;
Study Type: INTERVENTIONAL   |  Region: Colorado

---